UPS (NYSE: UPS) today announced the completion of its acquisition of Andlauer Healthcare Group Inc. (AHG), a leading North American supply chain management company headquartered in Canada. AHG is renowned for its customised third-party logistics and specialised cold chain transportation solutions for the healthcare and life sciences sectors.
Under the terms of the agreement, AHG shareholders will receive CAD $55.00 per share in cash, representing a total purchase price of approximately CAD $2.2 billion (USD $1.6 billion).
The acquisition reinforces UPS Healthcare’s commitment to being the world’s most reliable provider of complex, high-quality healthcare logistics. By integrating AHG’s advanced cold chain infrastructure and deep sector expertise, UPS Healthcare customers will gain reduced transit times, enhanced end-to-end visibility, expanded global reach, and industry-leading quality assurance across their supply chains.
Kate Gutmann, Executive Vice President and President of International, Healthcare and Supply Chain Solutions at UPS, said:
“At UPS Healthcare, we are relentlessly focused on quality, improving patient outcomes and advancing healthcare delivery, and we are thrilled that Andlauer Healthcare Group, and its talented employees, share that focus.
We will provide industry-leading services to our global customers, built on a foundation of quality, precision, and speed — all designed to help manage high-value, temperature-sensitive treatments.”
As part of the acquisition, Michael Andlauer, Founder and CEO of AHG, will lead UPS Canada Healthcare and AHG operations, further expanding the company’s specialised healthcare capabilities and advancing its mission to serve customers requiring sophisticated cold chain and pharmaceutical logistics solutions.
The combination of UPS’s global healthcare network and AHG’s North American cold chain leadership strengthens UPS’s position as a trusted logistics partner for the world’s most critical healthcare supply chains — from biologics and vaccines to precision medicine and medical devices.